Skip to main content
. 2018 Sep 3;41(11):zsy172. doi: 10.1093/sleep/zsy172

Table 2.

Participant characteristics by sleep duration categories: the Multi-Ethnic Study of Atherosclerosis (2010–2013), N = 2049

Participant characteristics Sleep duration categories, hr P*
<5.0
N = 267
5.0–5.9
N = 366
6.0–6.9
N = 649
7–8
N = 539
>8
N = 228
Age, mean years ± SD 69.2 ± 10.0 68.0 ± 9.0 67.6 ± 8.8 68.2 ± 9.0 71.7 ± 9.0 0.021
Female, n (%) 97 (36.3) 185 (50.6) 333 (51.3) 335 (62.2) 147 (64.5) <0.001
Race/ethnicity, n (%) <0.001
 Non-Hispanic white 62 (23.2) 90 (24.6) 256 (39.5) 258 (47.9) 112 (49.1)
 Chinese-American 36 (13.5) 45 (12.3) 65 (10.0) 63 (11.7) 18 (7.9)
 African American 116 (43.5) 130 (35.5) 181 (27.9) 96 (17.8) 37 (16.2)
 Hispanic 53 (19.9) 101 (27.6) 147 (22.7) 122 (22.6) 61 (26.8)
Education, n (%) 0.136
 Less than a high school diploma 35 (13.1) 45 (12.3) 82 (12.6) 77 (14.3) 48 (21.1)
 High school diploma or some college 122 (45.7) 175 (47.8) 311 (47.9) 242 (44.9) 96 (42.1)
 College degree or higher 110 (41.2) 146 (39.9) 256 (39.5) 220 (40.8) 84 (36.8)
Married/living with partner, n (%) 145 (54.3) 201 (54.9) 421 (64.9) 346 (64.2) 126 (55.3) <0.001
Smoking, n (%) <0.001
 Current 35 (13.1) 29 (7.9) 46 (7.1) 22 (4.1) 20 (8.8)
 Former 130 (48.7) 164 (44.8) 291 (44.8) 265 (49.2) 98 (43.0)
 Never 102 (38.2) 173 (47.3) 312 (48.1) 252 (46.8) 110 (48.3)
Presently drinking alcohol, n (%) 107 (40.1) 146 (39.9) 303 (46.7) 251 (46.6) 87 (38.2) 0.032
Hypnotic medication use ≥5 times/week, n (%) 15 (5.6) 19 (5.2) 36 (5.6) 41 (7.6) 17 (7.5) 0.450
CES-D ≥ 16, n (%) 51 (19.1) 71 (19.4) 79 (12.2) 68 (12.6) 34 (14.9) 0.004
BMI, mean kg/m2 ± SD (N = 2048) 29.9 ± 5.8 29.5 ± 5.7 28.8 ± 5.6 28.1 ± 5.4 28.2 ± 5.4 <0.001
Waist circumference, mean cm ± SD (N = 2046) 102.8 ± 14.6 101.2 ± 14.7 99.7 ± 14.7 97.3 ± 13.9 99.0 ± 14.6 <0.001
Sleep duration, mean hours ± SD 4.0 ± 0.9 5.6 ± 0.3 6.5 ± 0.3 7.4 ± 0.3 8.5 ± 0.5 <0.001
Sleep duration variability, mean ± SD 94.0 ± 36.9 87.1 ± 38.5 74.0 ± 37.4 65.2 ± 35.8 65.4 ± 32.4 <0.001
Sleep maintenance efficiency, median % ± IQR 91.2 ± 5.2 91.3 ± 4.6 91.7 ± 4.2 92.6 ± 3.9 92.9 ± 3.1 <0.001
Apnea–hypopnea index, median ± IQR (N = 1881) 14.8 ± 26.2 9.5 ± 15.8 7.8 ± 15.8 7.5 ± 15.9 8.3 ± 15.6 <0.001
Obstructive sleep apnea, n(%) (N = 1881) <0.001
 None 46 (18.6) 110 (32.9) 230 (38.1) 186 (37.4) 68 (34.3)
 Mild 81 (32.8) 113 (33.8) 176 (29.1) 155 (31.1) 67 (33.8)
 Moderate 52 (21.1) 69 (20.7) 117 (19.4) 87 (17.5) 34 (17.2)
 Severe 68 (27.5) 42 (12.6) 81 (13.4) 70 (14.1) 29 (14.7)
Nocturnal hypoxemia, median % ± IQR (N=1881) 1.8 ± 6.9 0.7 ± 3.7 0.6 ± 2.8 0.5 ± 2.7 0.6 ± 3.4 <0.001
HbA1c, mean ± SD 6.2 ± 1.1 6.0 ± 0.8 6.0 ± 0.9 5.9 ± 0.8 5.9 ± 0.8 <0.001

CES-D = Center for Epidemiologic Studies Depression Scale; IQR = interquartile range.

*p-Value tests for trend across sleep variability categories using one-way ANOVA or tests for a difference using Kruskal–Wallis or chi-square tests, as appropriate.

Percent of sleep time with oxyhemoglobin saturation <90%.